Ian Churcher
Company: Amphista Therapeutics
Job title: Chief Scientific Officer
Seminars:
4:00 New Degrading Mechanisms & Orally-Active Bifunctional Degraders By Design – Moving Beyond Cereblon 9:15 am
day: Day 1 Track A afternoon